JPS5811866B2 - Quinazoline Dione - Google Patents
Quinazoline DioneInfo
- Publication number
- JPS5811866B2 JPS5811866B2 JP48144504A JP14450473A JPS5811866B2 JP S5811866 B2 JPS5811866 B2 JP S5811866B2 JP 48144504 A JP48144504 A JP 48144504A JP 14450473 A JP14450473 A JP 14450473A JP S5811866 B2 JPS5811866 B2 JP S5811866B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- general formula
- hydrogen atom
- lower alkyl
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Description
【発明の詳細な説明】
本発明は顕著な消炎鎮痛作用を有する一般式(I)(式
中、R1は水素原子又はハロゲン原子を、R2はフェニ
ル基、又はハロゲン原子、低級アルキル基、低級アルコ
キシ基又はトリフルオロメチル基が1〜2個置換したフ
ェニル基又はベンジル基を、R3は水酸基、アルコキシ
基又はアシルオキシ基で置換された低級アルキル基を意
味する)で表わされるキナゾリンジオン誘導体の新規な
製造法に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention provides compounds of the general formula (I) (wherein R1 is a hydrogen atom or a halogen atom, and R2 is a phenyl group, or a halogen atom, a lower alkyl group, a lower alkoxy Novel production of quinazolinedione derivatives represented by a phenyl group or benzyl group substituted with 1 or 2 trifluoromethyl groups, R3 means a lower alkyl group substituted with a hydroxyl group, an alkoxy group or an acyloxy group) It is about law.
更に詳しくは、一般式(■)
(式中、Mは水素原子又は低級アルキル基を、R1及び
R2は前記と同じ意味を有する)で表わされる化合物に
一般式訓
R3NHCONHR4(■)
(式中、R3は前記と同じ意味を有し、R4は水素原子
又はR3と同じ意味を有する)で表わされる化合物とを
反応させ、前記一般式(I)で表わされる目的化合物を
製造する方法に関するものである。More specifically, the compound represented by the general formula (■) (wherein M is a hydrogen atom or a lower alkyl group, and R1 and R2 have the same meanings as above) is given the general formula R3NHCONHR4 (■) (wherein, R3 has the same meaning as above, and R4 has the same meaning as hydrogen atom or R3. .
前記一般式(1)、(II)及び(■)におけるR2に
ついて更に詳細に説明すると、R2はフェニル基、又は
塩素、臭素、弗素等のハロゲン原子、メチル、エチル等
の低級アルキル基、メトキシ、エトキシ等の低級アルコ
キシ基又はトリフルオロメチル基が任意の位置に1〜2
個置換したフェニル基を、又はベンジル基を表わす。To explain R2 in the general formulas (1), (II) and (■) in more detail, R2 is a phenyl group, a halogen atom such as chlorine, bromine, or fluorine, a lower alkyl group such as methyl or ethyl, methoxy, 1 to 2 lower alkoxy groups such as ethoxy or trifluoromethyl groups at any position
Represents a substituted phenyl group or a benzyl group.
従来、キナゾリン−2,4(1H,3H)−ジオン誘導
体を製造する方法としては、1一置換キナシリン−2,
4−(1H,3H)−ジオン誘導体の3位の水素原子を
ハイドロキシアルキル基、アルコキシアルキル基、アシ
ルオキシアルキル基等で置換する方法が知られているが
、この方法は原料、価格、製造工程、目的化合物の純度
及び収率等の点で必ずしも満足できるものではない。Conventionally, methods for producing quinazoline-2,4(1H,3H)-dione derivatives include 1-monosubstituted quinacillin-2,
A method is known in which the hydrogen atom at the 3-position of a 4-(1H,3H)-dione derivative is substituted with a hydroxyalkyl group, an alkoxyalkyl group, an acyloxyalkyl group, etc., but this method is limited by raw materials, cost, manufacturing process, The purity and yield of the target compound are not necessarily satisfactory.
本発明はこれらの点を改善したもので、本発明によれば
容易に高純度の目的化合物を製造することができる。The present invention improves these points, and according to the present invention, a highly pure target compound can be easily produced.
以下本発明について更に詳細な説明を加える。A more detailed explanation of the present invention will be given below.
一般式(II)で表わされる化合物としては、例えば2
−アニリノ安息香酸、2−(p−クロロアニリノ)安息
香酸、2−(m−クロロアニリノ)安息。Examples of the compound represented by general formula (II) include 2
-anilinobenzoic acid, 2-(p-chloroanilino)benzoic acid, 2-(m-chloroanilino)benzoic acid.
香酸、2−(m−ブロモアニリノ)安息香酸、2−(m
−メチルアニリノ)安息香酸、2−(m〜フルオロアニ
リノ)安息香酸、2−(m−)リフルオロメチルアニリ
ノ)安息香酸、4−クロロ−2−アニリノ安息香酸、4
−クロロ−2−(m−クロロアニリノ)安息香酸、4−
クロロ−2−(m−トリフルオロメチルアニリノ)安息
香酸、2−ベンジルアミノ安息香酸、2−(p−トリル
メチル)アミン安息香酸、2−(p−クロロフェニルメ
チル)アミン安息香酸及びこれらのエステルが適当であ
る。Froic acid, 2-(m-bromoanilino)benzoic acid, 2-(m
-methylanilino)benzoic acid, 2-(m~fluoroanilino)benzoic acid, 2-(m-)lifluoromethylanilino)benzoic acid, 4-chloro-2-anilinobenzoic acid, 4
-Chloro-2-(m-chloroanilino)benzoic acid, 4-
Chloro-2-(m-trifluoromethylanilino)benzoic acid, 2-benzylaminobenzoic acid, 2-(p-tolylmethyl)aminebenzoic acid, 2-(p-chlorophenylmethyl)aminebenzoic acid and esters thereof Appropriate.
又、一般式(■)で表わされる化合物としては、N−(
2−ハイドロキシエチル)尿素、N−エトキシメチル尿
素、N−(2−エトキシエチル)尿素及びN、N−ジ(
2−ハイドロキシエチル)尿素等が適当である。In addition, as a compound represented by the general formula (■), N-(
2-hydroxyethyl)urea, N-ethoxymethylurea, N-(2-ethoxyethyl)urea and N,N-di(
2-hydroxyethyl) urea and the like are suitable.
本発明を実施するには、一般式(lI)で表わされる化
合物と一般式(■)で表わされる化合物を100〜15
0℃で3〜4時間反応させることにより好収率にて製造
することができる。In order to carry out the present invention, the compound represented by the general formula (lI) and the compound represented by the general formula (■) must be mixed at 100 to 15
It can be produced in good yield by reacting at 0°C for 3 to 4 hours.
以下実施例により本発明を具体的に説明する。The present invention will be specifically explained below using Examples.
実施例 1
2−(m−トリフルオロメチルアニリノ)安息香酸メチ
ル10.FにN−(2−ハイドロキシエチル)尿素12
gを加えて油浴上150℃で3時間かきませたのち、反
応液をベンゼンと酢酸エチルとの混合溶媒に溶解し、シ
リカゲルを充填したカラムに吸着させてベンゼンと酢酸
エチルとの混合溶媒(混合比57:43)で展開し、溶
出液より溶媒を留去して残渣をメタノーレとエーテルか
ら再結晶して、無色プリズム晶の1−(m−トリフルオ
ロメチルフェニル)−3−(2−ハイドロキシエチル)
キナゾリン−2,4(1H,3H)−ジオン6.5gを
得た。Example 1 Methyl 2-(m-trifluoromethylanilino)benzoate 10. F is N-(2-hydroxyethyl)urea 12
After stirring on an oil bath at 150°C for 3 hours, the reaction solution was dissolved in a mixed solvent of benzene and ethyl acetate, and adsorbed on a column packed with silica gel to dissolve a mixed solvent of benzene and ethyl acetate ( The solvent was distilled off from the eluate and the residue was recrystallized from methanol and ether to give colorless prismatic crystals of 1-(m-trifluoromethylphenyl)-3-(2- hydroxyethyl)
6.5 g of quinazoline-2,4(1H,3H)-dione was obtained.
この物質の融点は139〜140℃であった。The melting point of this material was 139-140°C.
実施例 2
2−(m−クロロアニリノ)安息香酸メチル5.2gに
N−(2−エトキシエチル)尿素13gを加え油浴上1
50℃で4時間攪拌後、反応液をベンゼンと酢酸エチル
との混合溶媒に溶解し、シリカゲルを充填したカラムに
吸着させベンゼンと酢酸エチルとの混合溶媒(混合比5
7:43)で展開し、溶出液より溶媒を留去して残渣を
エタノールより再結晶して、無色プリズム晶の1−(m
−クロロフェニル)−3−(2−エトキシエチル)キナ
ゾリン−2,4(IH,3H)−ジオン3.6gを得た
。Example 2 13 g of N-(2-ethoxyethyl)urea was added to 5.2 g of methyl 2-(m-chloroanilino)benzoate, and the mixture was heated on an oil bath.
After stirring at 50°C for 4 hours, the reaction solution was dissolved in a mixed solvent of benzene and ethyl acetate, and adsorbed on a column packed with silica gel.
The solvent was distilled off from the eluate, and the residue was recrystallized from ethanol to obtain colorless prism crystals of 1-(m
3.6 g of -chlorophenyl)-3-(2-ethoxyethyl)quinazoline-2,4(IH,3H)-dione was obtained.
この物質の融点は115〜116℃であった。The melting point of this material was 115-116°C.
実施例 3〜20
実施例1〜2の方法に準じて次表の化合物を好収率で得
た。Examples 3-20 According to the method of Examples 1-2, the compounds shown in the following table were obtained in good yields.
Claims (1)
ェニル基、又はハロゲン原子、低級アルキル基、低級ア
ルコキシ基又はトリフルオロメチル基が1〜2個置換し
たフェニル基、又はベンジル基を、Mは水素原子又は低
級アルキル基を意味する)で表わされる化合物と一般式 %式% (式中、R3は水酸基、アルコキシ基又はアシルオキシ
基で置換された低級アルキル基を、R4は水素原子又は
R3と同じ意味を有する)で表わされる化合物とを10
0〜150℃で3〜4時間反応させることを特徴とする
一般式 (式中、R1,R2及びR3は前記と同じ意味を有する
)で表わされるキナゾリンジオン誘導体の製造方法。[Scope of Claims] 1 General formula (wherein R1 is a hydrogen atom or a halogen atom, R2 is a phenyl group, or substituted with 1 to 2 halogen atoms, lower alkyl groups, lower alkoxy groups, or trifluoromethyl groups) a phenyl group or a benzyl group, M means a hydrogen atom or a lower alkyl group) and a compound represented by the general formula % (wherein R3 is a lower alkyl group substituted with a hydroxyl group, an alkoxy group, or an acyloxy group) , R4 has the same meaning as hydrogen atom or R3) and 10
A method for producing a quinazolinedione derivative represented by the general formula (wherein R1, R2 and R3 have the same meanings as above), which comprises reacting at 0 to 150°C for 3 to 4 hours.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP48144504A JPS5811866B2 (en) | 1973-12-27 | 1973-12-27 | Quinazoline Dione |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP48144504A JPS5811866B2 (en) | 1973-12-27 | 1973-12-27 | Quinazoline Dione |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5095288A JPS5095288A (en) | 1975-07-29 |
| JPS5811866B2 true JPS5811866B2 (en) | 1983-03-04 |
Family
ID=15363886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP48144504A Expired JPS5811866B2 (en) | 1973-12-27 | 1973-12-27 | Quinazoline Dione |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5811866B2 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5038113B2 (en) * | 1971-10-07 | 1975-12-06 | ||
| JPS517674B2 (en) * | 1971-10-07 | 1976-03-10 |
-
1973
- 1973-12-27 JP JP48144504A patent/JPS5811866B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5095288A (en) | 1975-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019249562B2 (en) | Oxazole compound crystal | |
| AU2002250962B2 (en) | Process for the preparation of mesylates of piperazine derivatives | |
| US3993650A (en) | Pyrrolo [3,4-d] pyrimidines | |
| JPS60208957A (en) | Manufacture of pyrrolidone derivative | |
| JPS5995266A (en) | Indole derivative, manufacture of same and manufacture of beta-carboline-and tryptophane derivative | |
| Santilli et al. | 8, 9, 10, 11-Tetrahydro-12H-benzo [5, 6] quinoxalino-[2, 3-e][1, 4] diazepin-12-ones. Examples of a New Heterocyclic Ring System | |
| JPS5811866B2 (en) | Quinazoline Dione | |
| JPS589099B2 (en) | Quinazoline | |
| JPS5995286A (en) | Imidazo(4,5-c)pyridine-6-carboxylic acid derivative | |
| US4010159A (en) | Pyrrolo[3,4-d]pyrimidines and methods for their preparation | |
| JPS6323872A (en) | Manufacture of 6-amino-1,2-dihydro-1-hydroxy- 2-imino-4-piperidinopyrimidine | |
| US4482561A (en) | Therapeutically effective piperidyl N-(4-quinolyl)-anthraniloyloxyalkanoates | |
| JPS5813551B2 (en) | Sinquinapiride (4,3-D) Pyrimidinedione | |
| JPS6094973A (en) | Benzoxazolone derivative, production thereof and pharmaceutical composition containing the same | |
| JPS61205262A (en) | Fluorine-containing pyrimidine derivative | |
| JPS58429B2 (en) | Synquina 2-oxo-1,2,3,4-tetrahydropyride (2,3-D) Pyrimidine | |
| JPS6020387B2 (en) | Method for producing novel quinazoline derivatives | |
| JPH01104041A (en) | N-((2-oxo-1-pyrrolidinyl)acetyl)piperazine derivative, production thereof and remedy for senile dementia | |
| JPS582951B2 (en) | Sinquinapiride (2,3-D) Pyrimidinedione | |
| JPS5813547B2 (en) | Cinquinapiride (2,3-D) Pyrimidinedione | |
| JPS5920677B2 (en) | Method for producing a novel pyrimido[4,5-d]pyrimidinedione derivative | |
| JPH037266A (en) | 2-(4-phenyl-1-piperazinylalkyl)amino-5-ethynylpyrimidine derivative, its intermediate and production thereof | |
| JPS582943B2 (en) | Method for producing new imidazole derivatives | |
| JPS5813550B2 (en) | Sinquinapiride (4,3-D) Pyrimidinedione | |
| JPS5833233B2 (en) | Synquina pyridopyrimidine -2- |